insights_auto
Why is 038290 down 2.33%?
Dive Deeperchevron_right
038290:KOSDAQ
Macrogen Inc
â‚©12,180.00
arrow_downward
-2.33%(-290.00) 1D
Oct 8, 3:30:23 PM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 038290...
Open
â‚©12,460
High
â‚©12,460
Low
â‚©12,110
Mkt. cap
132.05B
Avg. vol.
16.03K
Volume
20.37K
Dividend
4.11%
Quarterly dividend
â‚©125
Ex-dividend date
Dec 27, 2024
P/E ratio
12.78
52-wk high
â‚©20,900
52-wk low
â‚©10,440
EPS
â‚©953
Shares outstanding
10.84M
No. of employees
473
Open
â‚©12,460
High
â‚©12,460
Low
â‚©12,110
Mkt. cap
132.05B
Avg. vol.
16.03K
Volume
20.37K
Dividend
4.11%
Quarterly dividend
â‚©125
Ex-dividend date
Dec 27, 2024
P/E ratio
12.78
52-wk high
â‚©20,900
52-wk low
â‚©10,440
EPS
â‚©953
Shares outstanding
10.84M
No. of employees
473
News stories
From web sources and news partners
Mitrade
·
35 minutes ago
Current S&P 500 Bull Market Turns 4 Monday and History Suggests More to Come
FOREX.com
·
1 day ago
S&P500 Forecast: SPX falls from record highs ahead of Fed minutes
BigGo Finance
·
4 hours ago
Tech Rebound Lifts All Three Major Indexes; Dow Posts Weekly Gain of Over 400 Points
ChartMill
·
7 hours ago
Friday's session: top gainers and losers in the dow jones index
Profile
Macrogen, Inc. is a South Korean public biotechnology company. The company's headquarters are located in Seoul. The company was founded in 1997 by Jeong-sun Seo, a professor at Seoul National University. It was venture capital-backed until its initial public offering and subsequent listing on the KOSDAQ market in 2000, making it the first Korean biotechnology firm to raise funds through an IPO. The company announced plans in 2010 to map the "Korean genome" based on the notion that United States-backed genome mapping efforts up to that time were representative of the "Caucasian genome" rather than the "Human genome" as claimed. By 2015, the company was described by one news outlet as "a global leader in personalized genomic medicine". Wikipedia
About Macrogen Inc